Diverse Options in Influenza Prevention and Control: How to Ensure Drug ...

As the flu season persists, drug quality control becomes a critical link in ensuring public medication safety. Drug impurity reference standards, serving as the "benchmark" in drug quality research,...

See More

Atrasentan Impurities—A Critical Quality Control Factor in IgA Nephro...

In August 2025, atrasentan hydrochloride tablets were officially approved by China‘s National Medical Products Administration (NMPA) for the reduction of proteinuria in adult patients wi...

See More

Full Set In Stock | Adrenaline Impurities Now Shining Bright!...

SZEB specializes in supplying Adrenaline impurity reference standards, including the N-NitrosoAdrenaline series and Adrenaline EP impurity series, to meet diverse experimental needs. Thes...

See More

Combination Nasal Spray Ryaltris® Disrupts the Rhinitis Market: How We...

On November 10th, the compound nasal spray containing Olopatadine Hydrochloride and Mometasone Furoate (brand name: Ryaltris®), jointly developed by Grand Pharmaceutical Group‘s subsidiary...

See More

Xanomeline : A Pioneering Non-Dopaminergic Therapy...

The fixed-dose combination drug Cobenfy (Kar XT), composed of xanomeline and trospium chloride, received FDA approval in September 2024 for the treatment of schizophrenia in adults. This mar...

See More

In Stock | Sacubitril impurity references...

Sacubitril Valsartan Sodium Tablets is the world‘s first commercially available angiotensin receptor-neprilysin inhibitor (ARNI). It was approved for marketing in 2017 by the National Medi...

See More

Udenafil Impurity Control and Scientific Innovation: Professional Pharmac...

Udenafil is a selective phosphodiesterase type 5 (PDE5) inhibitor. It is primarily used for the treatment of male erectile dysfunction (ED) and is also applied in the management of premature ej...

See More

China’s First Domestically Developed Dulaglutide Injection Approved for ...

On August 8, Boan Biotechnology announced that its independently developed Boyouping® (Dulaglutide Injection) has received market approval from the National Medical Products Administration...

See More

Crisaborole is Reshaping Atopic Dermatitis Treatment, Backed by SZEB Q...

Crisaborole is a boron-containing small-molecule anti-inflammatory drug, classified as a non-steroidal topical phosphodiesterase-4 (PDE-4) inhibitor. By inhibiting PDE-4, the drug increases th...

See More

Qilu Pharmaceutical Co.,Ltd.’s Carfilzomib for Injection Approved for M...

Qilu Pharmaceutical Co.,Ltd’s Carfilzomib for Injection has received market approval from the National Medical Products Administration (NMPA) of China for the treatment of adult patie...

See More

First-in-Class: FDA OKs Triple Therapy to Treat Hypertension...

Recently, George Medicines announced that its new drug Widaplik® (containing telmisartan, amlodipine, and indapamide, previously known as GMRx2) has been approved by the U.S. Food and Drug...

See More

LEQEMBI IQLIK™, the first-ever at-home subcutaneous injection for A...

The U.S. FDA has approved the lecanemab-irmb subcutaneous injection (U.S. brand name: LEQEMBI IQLIK™), jointly developed by Biogen and Eisai, for maintenance therapy in early A...

See More

Folic Acid Impurities: Reference Standards for Pharmaceutical Quality Co...

Beyond process-related impurities, factors such as light exposure, high temperatures, or humid conditions can cause the oxidation or degradation of folic acid, leading to the formation of new impurit...

See More

Lemborexant Impurity

Lemborexant is the first dual orexin receptor antagonist (DORA) approved for marketing in China. Developed by Eisai, it was first launched in the United States in December 2019 and received...

See More

Avibactam impurity

With the widespread application and in-depth research of avibactam, the analysis and control of its impurities and content have become increasingly important. During the synthesis and production of ...

See More

SZEB | Continuous Updates on Nitrosamine Impurities​...

Facing dynamic regulatory updates and the structural diversity of NDSRIs, ​​Shenzhen Superior Excellence Biotechnology (SZEB) responds rapidly by supplying relevant drug impurity refer...

See More

​​Breaking Dosage Form Barriers: Escitalopram Oxalate Drops Approval ...

the Escitalopram Oxalate Drops of Guangzhou Yipinhong Pharmaceutical Co., Ltd successfully obtained the drug registration certificate issued by the National Medical Products Administration...

See More

Isotretinoin Impurities: Professional Solutions of Reference Standards for...

As a critical drug for moderate-to-severe acne, Isotretinoin’s production and quality control are subject to rigorous regulatory standards. The Chinese Pharmacopoeia (2025 Edition)mandates that...

See More

CCBs Nitrosamine Impurities——Precise Drug References Empowering Drug...

Nitrosamine impurity control remains a global regulatory priority. For CCBs—the most widely prescribed antihypertensive class—robust identification and quantification of these impurities are cr...

See More

the first approval of an oro-dispersible film dosage form in China...

Qilu Pharmaceutical’s risperidone oro-dispersible film has been formally approved for market launch by the National Medical Products Administration (NMPA), marking the first approval of an ...

See More